CB
GILD icon

Chemical Bank’s Gilead Sciences GILD Stock Holding History

Chemical Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.42M Sell
21,009
-935
-4% -$61.5K 0.16% 141
2019
Q1 		$1.43M Sell
21,944
-2,039
-9% -$136K 0.16% 138
2018
Q4 		$1.5M Sell
23,983
-630
-3% -$44K 0.19% 121
2018
Q3 		$1.9M Sell
24,613
-1,348
-5% -$102K 0.2% 111
2018
Q2 		$1.84M Sell
25,961
-2,195
-8% -$155K 0.2% 110
2018
Q1 		$2.12M Sell
28,156
-987
-3% -$78.5K 0.23% 96
2017
Q4 		$2.09M Sell
29,143
-1,395
-5% -$106K 0.23% 103
2017
Q3 		$2.48M Sell
30,538
-1,740
-5% -$133K 0.27% 86
2017
Q2 		$2.28M Sell
32,278
-2,661
-8% -$177K 0.25% 92
2017
Q1 		$2.37M Sell
34,939
-33,751
-49% -$2.37M 0.26% 89
2016
Q4 		$4.92M Sell
68,690
-2,017
-3% -$150K 0.56% 42
2016
Q3 		$5.59M Sell
70,707
-73
-0.1% -$5.93K 0.75% 27
2016
Q2 		$5.9M Buy
70,780
+2,423
+4% +$215K 0.82% 25
2016
Q1 		$6.28M Buy
68,357
+1,240
+2% +$112K 0.88% 23
2015
Q4 		$6.79M Buy
67,117
+2,307
+4% +$240K 0.95% 21
2015
Q3 		$6.36M Sell
64,810
-116
-0.2% -$12.9K 0.92% 21
2015
Q2 		$7.6M Sell
64,926
-11
-0% -$1.2K 1.01% 17
2015
Q1 		$6.37M Buy
64,937
+3,030
+5% +$308K 0.83% 27
2014
Q4 		$5.84M Buy
61,907
+7,175
+13% +$742K 0.76% 31
2014
Q3 		$5.83M Buy
54,732
+803
+1% +$78.6K 1.01% 14
2014
Q2 		$4.47M Buy
53,929
+1,078
+2% +$83.9K 0.76% 29
2014
Q1 		$3.75M Sell
52,851
-971
-2% -$76.2K 0.67% 34
2013
Q4 		$4.04M Sell
53,822
-10,480
-16% -$730K 0.72% 30
2013
Q3 		$4.04M Sell
64,302
-229
-0.4% -$13.7K 0.78% 25
2013
Q2 		$3.31M Buy
+64,531
New +$3.36M 0.65% 33

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Chemical Bank's GILD Position: Q2 2019 in Review

Chemical Bank reduced its Gilead Sciences (GILD) stake by 4.3% in Q2 2019, selling an estimated $61.5K and leaving 21,009 shares worth $1.42M. The position accounts for 0.16% of the portfolio, ranked #141.

Chemical Bank first reported a position in GILD in Q2 2013 and has held it in 25 quarters since. The position peaked at $7.6M in Q2 2015. 1,484 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Chemical Bank held 21,009 shares of Gilead Sciences worth $1.42M as of Q2 2019.
  • Chemical Bank sold 935 Gilead Sciences shares in Q2 2019, an estimated $61.5K.
  • Gilead Sciences made up 0.16% of Chemical Bank's portfolio in Q2 2019, its #141 holding.
  • Chemical Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's Gilead Sciences position peaked at $7.6M in Q2 2015.
  • 1,484 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.